These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8262485)

  • 1. In vivo metabolic defects in non-insulin-dependent diabetes mellitus.
    Bonadonna RC
    Horm Res; 1993; 39 Suppl 3():102-6. PubMed ID: 8262485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the pathophysiology of late onset non-insulin dependent diabetes mellitus. Current controversies and new insights.
    Vaag A
    Dan Med Bull; 1999 Jun; 46(3):197-234. PubMed ID: 10421979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in type II diabetes mellitus.
    Rizza R; Butler P
    Adv Second Messenger Phosphoprotein Res; 1990; 24():511-6. PubMed ID: 2169826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of hepatic glucose production in healthy subjects and patients with non-insulin-dependent diabetes mellitus.
    Tappy L
    Diabete Metab; 1995 Oct; 21(4):233-40. PubMed ID: 8529757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.
    Vestergaard H; Bjørbaek C; Hansen T; Larsen FS; Granner DK; Pedersen O
    J Clin Invest; 1995 Dec; 96(6):2639-45. PubMed ID: 8675629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic effects of hyperglycaemia on glucose metabolism: implications for the development of new therapies.
    Yki-Järvinen H
    Diabet Med; 1997 Aug; 14 Suppl 3():S32-7. PubMed ID: 9272611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin resistance and non-insulin dependent diabetes mellitus].
    Pelikánová T
    Vnitr Lek; 1995 Feb; 41(2):99-103. PubMed ID: 7725647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defect of an early event of glucose metabolism in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty (OLETF) rat, a non-insulin-dependent diabetes mellitus (NIDDM) model.
    Sato T; Magata K; Koga N; Mitsumoto Y
    Biochem Biophys Res Commun; 1998 Apr; 245(2):378-81. PubMed ID: 9571158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New concepts in extracellular signaling for insulin action: the single gateway hypothesis.
    Bergman RN
    Recent Prog Horm Res; 1997; 52():359-85; discussion 385-7. PubMed ID: 9238859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
    Bitar MS; Al-Saleh E; Al-Mulla F
    Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
    Hrnciar J
    Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes.
    Björnholm M; Zierath JR
    Biochem Soc Trans; 2005 Apr; 33(Pt 2):354-7. PubMed ID: 15787605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of obesity on insulin action in NIDDM.
    Campbell PJ; Carlson MG
    Diabetes; 1993 Mar; 42(3):405-10. PubMed ID: 8432411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
    Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
    Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiopathological fundamentals of type 2 diabetes].
    Girard J
    Rev Prat; 1999 Jan; 49(1):22-9. PubMed ID: 9926712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue.
    Lauro D; Kido Y; Castle AL; Zarnowski MJ; Hayashi H; Ebina Y; Accili D
    Nat Genet; 1998 Nov; 20(3):294-8. PubMed ID: 9806552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes mellitus and skeletal muscle metabolic function.
    Phielix E; Mensink M
    Physiol Behav; 2008 May; 94(2):252-8. PubMed ID: 18342897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.